STUDYING THE INFLUENCE OF CONSEQUENCES OF COVID-19 ON THE COURSE OF ANKYLOSING SPONDYLITIS
Keywords:
ankylosing spondylitis, COVID-19, functional activityAbstract
Target. The purpose of the research was analysis of the level of the cartilage oligomeric matrix protein (COMP) of patients with osteoarthritis according to the current course of the syndrome and to detect changes in the knee joint
To improve the treatment of osteoarthritis in patients with osteoarthritis due to the degree of oligomer matrix oxide
References
Haubner, B., Tanner, F. C., Ruschitzka, F., Flammer, A. J., & Matthias, P. N. Endothelial dysfunction in COVID-19: current findings and therapeutic implications. //Atherosclerosis, 314(2020), 58–62.
Azevedo, R. B., Botelho, B. G., Hollanda, J. V. G. de, Ferreira, L. V. L., Junqueira de Andrade, L. Z., Oei, S. S. M. L., Mello, T. de S., & Muxfeldt, E. S. (2021). Covid-19 and the cardiovascular system: a comprehensive review. //Journal of Human Hypertension, 35(1), 4–11
D’Antiga, L. (2020). Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic. //Liver Transplantation, 26(6), 832–834
Coskun Benlidayi, I., Kurtaran, B., Tirasci, E., & Guzel, R. (2020). Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review. //Rheumatology International, 40(10), 1707–1716
Uhrin, Z., Kuzis, S., & Ward, M. M. (n.d.). Exercise and Changes in Health Status in Patients With Ankylosing Spondylitis. Retrieved August 22, 2021
Liew, J. W., Castillo, M., Zaccagnino, E., Katz, P., Haroon, N., & Gensler, L. S. (2020). Patient-reported Disease Activity in an Axial Spondyloarthritis Cohort during the COVID-19 Pandemic. 2(9), 533–539.
Iegudina, I. D., Syniachenko, O. V., Ermolaeva, M. V., Chernyshova, O. E., Polesovа, T. R., & Khaniukov, A. A. (2017). Vascular rheological properties of the blood in ankylosing spondylitis. //Trauma, 18(1), 80–86.
Haubner, B., Tanner, F. C., Ruschitzka, F., Flammer, A. J., & Matthias, P. N. (2020). Endothelial dysfunction in COVID-19: current findings and therapeutic implications. //Atherosclerosis, 314(2020), 58–62.
Roux, C. H., Brocq, O., Gerald, F., Pradier, C., & Bailly, L. (2020). Clinical impact of COVID-19 on a French population of spondyloarthritis patients. // Clinical Rheumatology (Vol. 39, Issue 11, pp. 3185–3187). Springer Science and Business Media Deutschland GmbH
Łosińska, K., Korkosz, M., & Kwaśny-Krochin, B. (2019). Endothelial dysfunction in patients with ankylosing spondylitis. //Reumatologia, 57(2), 100–105
Abdurakhmanova N.M., Akhmedov Kh.S. " Kliniko- funksionalnie osobennosti techeniya ankiloziruyushego spondiloartrita u bolnix, perenesshix COVID-19 ". //Nauchno- practicheskiy jurnal “Infeksiya, immunitet I farmakologiya” (4/2021), p. 20-23
Rakhimova, M. B., Kh S. Akhmedov, and Y. A. Turaev. "Endothelial dysfunction as a link in the pathogenesis of ankylosing spondylitis against the background of a new coronavirus infection." // ACADEMICIA: An International Multidisciplinary Research Journal 11.3 (2021): 2493-2498.
